本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

335.28
+3.671.11%
盤後335.280.00000.00%19:12 EST
成交量:64.87萬
成交額:2.17億
市值:91.89億
市盈率:-25.94
高:349.32
開:332.52
低:314.39
收:331.61
52周最高:349.32
52周最低:26.70
股本:2,740.71萬
流通股本:2,292.25萬
量比:1.57
換手率:2.83%
股息:- -
股息率:- -
每股收益(TTM):-12.9227
每股收益(LYR):-10.2095
淨資產收益率:-45.83%
總資產收益率:-28.69%
市淨率:10.46
市盈率(LYR):-32.84

資料載入中...

公司資料

公司名字:
Praxis Precision Medicines, Inc.
交易所:
NASDAQ
成立時間:
2015
員工人數:
116
公司地址:
99 High Street,30th Floor,Boston,Massachusetts,United States
郵編:
02110
電話:
傳真:
- -
簡介:
Praxis Precision Medicines, Inc.於2015年9月22日根據特拉華州法律成立。該公司是一家臨床階段的生物製藥公司,將遺傳見解轉化為中樞神經系統(CNS)治療方法的發展,CNS是以神經元失衡為特徵的疾病。

董事

名稱
職位
Dean Mitchell
Chairman of the Board
Marcio Souza
Director, President and Chief Executive Officer
Gregory Norden
Independent Director
Jeffrey B. Kindler
Independent Director
Jeffrey Chodakewitz
Independent Director
Jill DeSimone
Independent Director
Merit Cudkowicz
Independent Director
Stuart A. Arbuckle
Independent Director
William Young
Independent Director

股東

名稱
職位
Marcio Souza
Director, President and Chief Executive Officer
Megan Sniecinski
Chief Operating Officer
Timothy Kelly
Chief Financial Officer
Alex Nemiroff
General Counsel and Secretary
Lauren Mastrocola
Principal Accounting Officer